X-8170052-C-G

Variant summary

Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_016378.3(VCX2):ā€‹c.400G>Cā€‹(p.Val134Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000036 in 1,195,242 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 12 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: š‘“ 0.000020 ( 0 hom., 0 hem., cov: 15)
Exomes š‘“: 0.000037 ( 0 hom. 12 hem. )

Consequence

VCX2
NM_016378.3 missense

Scores

1
16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -3.12
Variant links:
Genes affected
VCX2 (HGNC:18158): (variable charge X-linked 2) This gene belongs to the VCX/Y gene family, which has multiple members on both X and Y chromosomes that are expressed exclusively in male germ cells. The VCX gene cluster is polymorphic in terms of copy number; different individuals may have a different number of VCX genes. This gene contains two copies of a 30 nt tandem repeat. Deletion of a nearby member of this family was implicated in cognitive disability. [provided by RefSeq, Feb 2015]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.02288273).
BS2
High Hemizygotes in GnomAdExome4 at 12 gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
VCX2NM_016378.3 linkuse as main transcriptc.400G>C p.Val134Leu missense_variant 3/3 ENST00000317103.5 NP_057462.2
LOC107985675XR_001755783.2 linkuse as main transcriptn.1915-58283C>G intron_variant, non_coding_transcript_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
VCX2ENST00000317103.5 linkuse as main transcriptc.400G>C p.Val134Leu missense_variant 3/31 NM_016378.3 ENSP00000321309 P1
ENST00000659022.1 linkuse as main transcriptn.972-58283C>G intron_variant, non_coding_transcript_variant
ENST00000649338.1 linkuse as main transcriptn.263-58283C>G intron_variant, non_coding_transcript_variant

Frequencies

GnomAD3 genomes
AF:
0.0000203
AC:
2
AN:
98726
Hom.:
0
Cov.:
15
AF XY:
0.00
AC XY:
0
AN XY:
22278
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000408
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000110
AC:
2
AN:
181740
Hom.:
0
AF XY:
0.0000296
AC XY:
2
AN XY:
67640
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000248
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000374
AC:
41
AN:
1096516
Hom.:
0
Cov.:
76
AF XY:
0.0000331
AC XY:
12
AN XY:
362862
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000475
Gnomad4 OTH exome
AF:
0.0000217
GnomAD4 genome
AF:
0.0000203
AC:
2
AN:
98726
Hom.:
0
Cov.:
15
AF XY:
0.00
AC XY:
0
AN XY:
22278
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000408
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.00000756
ExAC
AF:
0.0000166
AC:
2

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsMar 21, 2022The c.400G>C (p.V134L) alteration is located in exon 3 (coding exon 2) of the VCX2 gene. This alteration results from a G to C substitution at nucleotide position 400, causing the valine (V) at amino acid position 134 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.15
BayesDel_addAF
Benign
-0.55
T
BayesDel_noAF
Benign
-0.97
CADD
Benign
0.0070
DANN
Benign
0.086
DEOGEN2
Benign
0.00034
T
FATHMM_MKL
Benign
0.00091
N
LIST_S2
Benign
0.36
T
M_CAP
Benign
0.0034
T
MetaRNN
Benign
0.023
T
MetaSVM
Benign
-0.95
T
MutationAssessor
Benign
-1.8
N
MutationTaster
Benign
1.0
N
PrimateAI
Uncertain
0.52
T
PROVEAN
Benign
0.15
N
REVEL
Benign
0.031
Sift
Benign
1.0
T
Sift4G
Benign
1.0
T
Polyphen
0.087
B
Vest4
0.092
MutPred
0.13
Loss of catalytic residue at V134 (P = 0.0059);
MVP
0.048
MPC
0.0091
ClinPred
0.031
T
GERP RS
-0.093
Varity_R
0.10
gMVP
0.0014

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs148114540; hg19: chrX-8138093; API